Macular Degeneration

The United Kingdom is often praised for spending as little as half as much per capita on health care as the United States.  Credit for this cost containment goes in large part to the National Institute for Health and Clinical Excellence, or NICE.  Americans should understand how NICE works because under ObamaCare it will eventually be coming to a hospital near you, says the Wall Street Journal. The British officials who established NICE in the late 1990s pitched it as a body that would ensure t

A second clinical trial authorization expected, this time in the United Kingdom, to treat an eye disease called macular degeneration, a condition that leads to vision loss in central retina. British researchers hope to obtain approval …

Macular degeneration, the leading cause of blindness in Britain, causes loss of central vision. Although the National Institute for Health and Clinical Excellence (Nice) has approved the drug Lucentis for use in patients aged 50 or …

According to the Macular Degeneration Foundation, macular degeneration is the number one cause of blindness among persons aged over 65 in the United States and the United Kingdom. Some good news, though, was revealed in a study published in the Archives of Internal Medicine.

The United Kingdom is often praised for spending as little as half as much per capita on health care as the United States. Credit for this cost containment goes in large part to the National Institute for Health and Clinical Excellence, …